Cigarette, shisha, and electronic smoking and respiratory symptoms in Swiss children: The LUIS study.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
10 2020
Historique:
received: 29 05 2020
revised: 10 07 2020
accepted: 20 07 2020
pubmed: 28 7 2020
medline: 2 3 2021
entrez: 28 7 2020
Statut: ppublish

Résumé

Smoking habits in adolescents are changing. We assessed active smoking of conventional cigarettes, e-cigarettes and shishas in Swiss schoolchildren, studied risk factors and compared respiratory problems between smokers and non-smokers. We used data from LuftiBus in the school (LUIS), a school-based survey of respiratory health of children carried out 2013 to 2016 in the canton of Zurich, Switzerland. Participants were asked about use of cigarettes, shishas, and electronic smoking devices (ESD), and current respiratory symptoms. We studied associations between smoking and risk factors using logistic regression. We included 3488 schoolchildren. Among 6 to 12-year-olds, 90/1905 (5%) had smoked occasionally (<once/week). Among 13 to 17-year-olds, 563/1583 (36%) had smoked occasionally of whom 414 smoked ESDs, 409 shishas, and 276 cigarettes. Among 13 to 17-year-olds who smoked frequently (≥once/week), 41/54 (76%) smoked cigarettes. A 22% of 15 to 17-year-olds (104/477) had used all three products. Smoking was more common in adolescents who were male (adjusted OR, 2.1; 95% CI, 1.7-2.6), lived in rural areas (1.8, 95% CI, 1.2-2.9 vs small urban), and whose mother (1.7, 95% CI, 1.3-2.3) or father (1.5, 95% CI, 1.2-1.9) smoked. Current respiratory symptoms like rhinitis, dyspnea, and wheeze were more common among frequent smokers (44%, 30%, 12%, respectively) and occasional smokers (32%, 22%, 13%) than in never smokers (29%,19%, 8%, P for trend <.05). Smoking of shishas and ESDs is common among Swiss adolescents and often combined with smoking cigarettes. Adolescent smokers reported more respiratory symptoms than never smokers. We recommend smoking preventive strategies that include all forms of smoking.

Sections du résumé

BACKGROUND
Smoking habits in adolescents are changing. We assessed active smoking of conventional cigarettes, e-cigarettes and shishas in Swiss schoolchildren, studied risk factors and compared respiratory problems between smokers and non-smokers.
METHODS
We used data from LuftiBus in the school (LUIS), a school-based survey of respiratory health of children carried out 2013 to 2016 in the canton of Zurich, Switzerland. Participants were asked about use of cigarettes, shishas, and electronic smoking devices (ESD), and current respiratory symptoms. We studied associations between smoking and risk factors using logistic regression.
RESULTS
We included 3488 schoolchildren. Among 6 to 12-year-olds, 90/1905 (5%) had smoked occasionally (<once/week). Among 13 to 17-year-olds, 563/1583 (36%) had smoked occasionally of whom 414 smoked ESDs, 409 shishas, and 276 cigarettes. Among 13 to 17-year-olds who smoked frequently (≥once/week), 41/54 (76%) smoked cigarettes. A 22% of 15 to 17-year-olds (104/477) had used all three products. Smoking was more common in adolescents who were male (adjusted OR, 2.1; 95% CI, 1.7-2.6), lived in rural areas (1.8, 95% CI, 1.2-2.9 vs small urban), and whose mother (1.7, 95% CI, 1.3-2.3) or father (1.5, 95% CI, 1.2-1.9) smoked. Current respiratory symptoms like rhinitis, dyspnea, and wheeze were more common among frequent smokers (44%, 30%, 12%, respectively) and occasional smokers (32%, 22%, 13%) than in never smokers (29%,19%, 8%, P for trend <.05).
CONCLUSION
Smoking of shishas and ESDs is common among Swiss adolescents and often combined with smoking cigarettes. Adolescent smokers reported more respiratory symptoms than never smokers. We recommend smoking preventive strategies that include all forms of smoking.

Identifiants

pubmed: 32716136
doi: 10.1002/ppul.24985
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2806-2815

Subventions

Organisme : Swiss National Science Foundation
ID : 320030_173044
Pays : Switzerland
Organisme : Swiss National Science Foundation
ID : P200P3_185923
Pays : Switzerland

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885-1906.
Mattli R, Farcher R, Dettling M, Syleouni M-E, Wieser S Die Krankheitslast des Tabakkonsums in der Schweiz: Schätzung für 2015 und Prognose bis 2050. In. Winterthur: Zürcher Hochschule für angewandte Wissenschaften; 2019.
Swiss Federal Office of Health. Addition Monitoring in Switzerland. www.suchtmonitoring.ch. Accessed March 1, 2020.
Gmel G, Kuendig H, Notari L, Gmel C. Suchtmonitoring Schweiz - Konsum von Alkohol, Tabak und illegalen Drogen in der Schweiz im Jahr 2016. Sucht Schweiz, Lausanne, Schweiz. 2017.
Delgrande Jordan M, Schneider E, Eichenberger Y, Kretschmann A La consommation de substances psychoactives des 11 à 15 ans en Suisse-Situation en 2018 et évolutions depuis 1986-Résultats de l’étude Health Behaviour in School-aged Children (HBSC) (rapport de recherche No 100). 2019.
Gentzke AS, Creamer M, Cullen KA, et al. Vital signs: tobacco product use among middle and high school students-United States, 2011-2018. MMWR Morb Mortal Wkly Rep. 2019;68(6):157-164.
King BA, Gammon DG, Marynak KL, Rogers T. Electronic cigarette sales in the United States, 2013-2017. JAMA. 2018;320(13):1379-1380.
Huang J, Duan Z, Kwok J, et al. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control. 2019;28(2):146-151.
Bals R, Boyd J, Esposito S, et al. Electronic cigarettes: a task force report from the European Respiratory Society. Eur Respir J. 2019;53:2.
Gotts JE, Jordt SE, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes? BMJ. 2019;366:367.
Mallol J, Castro-Rodriguez JA, Cortez E. Effects of active tobacco smoking on the prevalence of asthma-like symptoms in adolescents. Int J Chronic Obstruct Pulm Dis. 2007;2(1):65-69.
Cho JH, Paik SY. Association between electronic cigarette use and asthma among high school students in South Korea. PLoS One. 2016;11(3):e0151022.
McConnell R, Barrington-Trimis JL, Wang K, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med. 2017;195(8):1043-1049.
Soneji S, Barrington-Trimis JL, Wills TA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(8):788-797.
Kuehni CE, Barben J. Protecting children from second-hand smoke. Eur Respir J. 2015;46(3):601-603.
Ferkol TW, Farber HJ, La Grutta S, et al. Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies. Eur Respir J. 2018;51:5.
Delgrande Jordan M, Eichenberger Y, Kretschmann A, Schneider E Eine explorative Untersuchung des Zusammenhangs zwischen dem Konsum psychoaktiver Substanzen und Merkmalen 11- bis 15-jähriger Jugendlicher in der Schweiz-Ergebnisse der Studie «Health Behaviour in School-aged Children» (HBSC) 2018 (Forschungsbericht Nr. 105). Lausanne: Sucht Schweiz. 2019.
Fleischer NL, Donahoe JT, McLeod MC, et al. Taxation reduces smoking but may not reduce smoking disparities in youth. Tob Control. 2020;0 1-9.
Bonnie RJ, Stratton K, Kwan LY, eds. undefinedPublic Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products. Washington DC: National Academies Press; 2015.
Kuehni CE, Brooke AM, Strippoli MP, Spycher BD, Davis A, Silverman M. Cohort profile: the Leicester respiratory cohorts. Int J Epidemiol. 2007;36(5):977-985.
Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8(3):483-491.
Braegger C, Jenni O, Konrad D, Molinari L. Neue Wachstumskurven für die Schweiz. Paediatrica. 2011;22:n1.
Bopp M, Spoerri A, Zwahlen M, et al. Cohort profile: the Swiss National Cohort-a longitudinal study of 6.8 million people. Int J Epidemiol. 2009;38(2):379-384.
Panczak R, Galobardes B, Voorpostel M, Spoerri A, Zwahlen M, Egger M. A Swiss neighbourhood index of socioeconomic position: development and association with mortality. J Epidemiol Community Health. 2012;66(12):1129-1136.
Swiss Federal Office of Statistics. Räumliche Gliederungen. https://www.bfs.admin.ch/bfs/de/home/statistiken/querschnittsthemen/raeumliche-analysen/raeumliche-gliederungen.html
Laverty AA, Filippidis FT, Taylor-Robinson D, Millett C, Bush A, Hopkinson NS. Smoking uptake in UK children: analysis of the UK Millennium Cohort Study. Thorax. 2019;74(6):607-610.
Pförtner TK, De Clercq B, Lenzi M, et al. Does the association between different dimension of social capital and adolescent smoking vary by socioeconomic status? a pooled cross-national analysis. Int J Public Health. 2015;60(8):901-910.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-349.
WHO. HBSC international report: growing up unequal. 2016.
Jakob J, Cornuz J, Diethelm P. Prevalence of tobacco smoking in Switzerland: do reported numbers underestimate reality? Swiss Med Wkly. 2017;147:w14437.
Joossens L, Raw M The tobacco control scale 2013 in Europe. A report of the Association of European Cancer Leagues. 2014.
Selya AS, Dierker LC, Rose JS, Hedeker D, Mermelstein RJ. Risk factors for adolescent smoking: parental smoking and the mediating role of nicotine dependence. Drug Alcohol Depend. 2012;124(3):311-318.
Hanewinkel R, Isensee B. Risk factors for e-cigarette, conventional cigarette, and dual use in German adolescents: a cohort study. Prev Med. 2015;74:59-62.
Ziller EC, Lenardson JD, Paluso NC, Talbot JA, Daley A. Rural-urban differences in the decline of adolescent cigarette smoking. Am J Public Health. 2019;109(5):771-773.
Oelsner EC, Balte PP, Bhatt SP, et al. Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study. Lancet Respir Med. 2020;8(1):34-44.
Wang MP, Ho SY, Leung LT, Lam TH. Electronic cigarette use and respiratory symptoms in Chinese adolescents in Hong Kong. JAMA Pediatr. 2016;170(1):89-91.
Pisinger C, Dagli E, Filippidis FT, et al. ERS and tobacco harm reduction. Eur Respir J. 2019;54:6.
Lovato C, Watts A, Stead LF. Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours. Cochrane Database Syst Rev. 2011;0 (10).
Fadus MC, Smith TT, Squeglia LM. The rise of e-cigarettes, pod mod devices, and JUUL among youth: factors influencing use, health implications, and downstream effects. Drug Alcohol Depend. 2019;201:85-93.
Perrine CG, Pickens CM, Boehmer TK, et al. Characteristics of a multistate outbreak of lung injury associated with e-cigarette use, or vaping-United States, 2019. MMWR Morbidity and mortality weekly report. 2019;68(39):860-864.

Auteurs

Rebeca Mozun (R)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Cristina Ardura-Garcia (C)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Carmen C M de Jong (CCM)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Myrofora Goutaki (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Paediatric Respiratory Medicine, Children's University Hospital of Bern, University of Bern, Bern, Switzerland.

Jakob Usemann (J)

Division of Respiratory Medicine, University Children's Hospital Zurich and Childhood Research Center, University of Zurich, Zurich, Switzerland.
University Children's Hospital Basel (UKBB), Basel, Switzerland.

Florian Singer (F)

Paediatric Respiratory Medicine, Children's University Hospital of Bern, University of Bern, Bern, Switzerland.
PEDNET, Paediatric Clinical Trial Unit, Children's University Hospital of Bern, University of Bern, Bern, Switzerland.

Philipp Latzin (P)

Paediatric Respiratory Medicine, Children's University Hospital of Bern, University of Bern, Bern, Switzerland.

Claudia E Kuehni (CE)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Paediatric Respiratory Medicine, Children's University Hospital of Bern, University of Bern, Bern, Switzerland.

Alexander Moeller (A)

Division of Respiratory Medicine, University Children's Hospital Zurich and Childhood Research Center, University of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH